Ganfort PF

Ganfort PF Overdosage

bimatoprost + timolol

Manufacturer:

AbbVie

Distributor:

DKSH
Full Prescribing Info
Overdosage
Overdose and Treatment: No information is available on overdosage with Ganfort PF in humans. If overdosage occurs, treatment should be symptomatic and supportive; a patient airway should be maintained.
If Ganfort PF is accidentally ingested, the following information may be useful: in 2-week oral rat and mouse studies, doses of bimatoprost up to 100 mg/kg/day did not produce any toxicity.
This dose is at least 22 times higher than the amount of bimatoprost to which a 10 kg child would be exposed were it to accidentally ingest the entire content of a package (30 unit dose vials; 0.4 mL per vial; 12 mL) of bimatoprost 0.03% ophthalmic solution.
There have been reports of inadvertent overdosage with timolol ophthalmic solution resulting in systemic effects similar to those seen with systemic beta-adrenergic blocking agents such as dizziness, headache, shortness of breath, bradycardia, hypotension, bronchospasm, and cardiac arrest. An in vitro hemodialysis study, using 14C timolol added to human plasma or whole blood showed that timolol was readily dialyzed from these fluids; however, a study of patients with renal failure showed that timolol did not dialyze readily.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in